Cardioprotective actions of verapamil on the β-adrenergic receptor complex in acute canine Chagas' disease

Gexin Chen, Stephen Barr, Diane Walsh, Shira Rohde, Andrew Brewer, John P. Bilezikian, Murray Wittner, Herbert B. Tanowitz, Stephen A. Morris

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

The effect of verapamil treatment on the myocardial β-adrenergic adenylyl cyclase complex in acute canine Chagas' disease was investigated. Relative to uninfected animals, 30 days of infection with T. cruzi reduced myocardial adenylyl cyclase activity by over 75%. With continuous verapamil treatment, the infection-associated reduction in adenylyl cyclase activity was less than 50%. The individual components of the β-adrenergic receptor complex were characterized. Infection: (1) increased right ventricular (RV) β-adrenergic receptor (βAR) density five-fold; (2) decreased left ventricle βAR density by 20%; (3) reduced the proportion of high-affinity βAR receptors to the same extent in both left and right ventricles; (4) reduced α(s) by 50% as determined by Western blot analysis, increased α(il-3) but did not change a0; and (5) decreased the magnitude of pertussis-toxin-dependent [32P]ADP ribosylation by 60% as well as the proportion of [32P]ADP-ribose incorporated in a0. Verapamil treatment of infected animals restored RV βAR receptor density, α(s) and α(il-3) to control levels but had no influence on any aspect of pertussis-toxin-dependent [32P]ADP-ribosylation. Verapamil treatment of uninfected animals also: (1) increased β-adrenergic adenylyl cyclase activity; (2) increased βAR density in the RV but not the LV; (3) reduced high- to low-affinity β-adrenergic receptors; and (4) affected only α(i2) (50% decrease). The results indicate that the major actions of verapamil on the β-adrenergic adenylyl cyclase complex in acute canine Chagas' disease may help to account for its cardioprotective effects.

Original languageEnglish (US)
Pages (from-to)931-941
Number of pages11
JournalJournal of Molecular and Cellular Cardiology
Volume28
Issue number5
DOIs
StatePublished - May 1996
Externally publishedYes

Fingerprint

Dog Diseases
Chagas Disease
Verapamil
Adrenergic Receptors
Adenylyl Cyclases
Adrenergic Agents
Heart Ventricles
Pertussis Toxin
Adenosine Diphosphate
Infection
Animal Rights
Adenosine Diphosphate Ribose
Western Blotting

Keywords

  • b-adrenergic receptor
  • Chagas' cardiomyopathy
  • Verapamil

ASJC Scopus subject areas

  • Molecular Biology
  • Cardiology and Cardiovascular Medicine

Cite this

Cardioprotective actions of verapamil on the β-adrenergic receptor complex in acute canine Chagas' disease. / Chen, Gexin; Barr, Stephen; Walsh, Diane; Rohde, Shira; Brewer, Andrew; Bilezikian, John P.; Wittner, Murray; Tanowitz, Herbert B.; Morris, Stephen A.

In: Journal of Molecular and Cellular Cardiology, Vol. 28, No. 5, 05.1996, p. 931-941.

Research output: Contribution to journalArticle

Chen, G, Barr, S, Walsh, D, Rohde, S, Brewer, A, Bilezikian, JP, Wittner, M, Tanowitz, HB & Morris, SA 1996, 'Cardioprotective actions of verapamil on the β-adrenergic receptor complex in acute canine Chagas' disease', Journal of Molecular and Cellular Cardiology, vol. 28, no. 5, pp. 931-941. https://doi.org/10.1006/jmcc.1996.0087
Chen, Gexin ; Barr, Stephen ; Walsh, Diane ; Rohde, Shira ; Brewer, Andrew ; Bilezikian, John P. ; Wittner, Murray ; Tanowitz, Herbert B. ; Morris, Stephen A. / Cardioprotective actions of verapamil on the β-adrenergic receptor complex in acute canine Chagas' disease. In: Journal of Molecular and Cellular Cardiology. 1996 ; Vol. 28, No. 5. pp. 931-941.
@article{84905841db8b43e092521b133964ae83,
title = "Cardioprotective actions of verapamil on the β-adrenergic receptor complex in acute canine Chagas' disease",
abstract = "The effect of verapamil treatment on the myocardial β-adrenergic adenylyl cyclase complex in acute canine Chagas' disease was investigated. Relative to uninfected animals, 30 days of infection with T. cruzi reduced myocardial adenylyl cyclase activity by over 75{\%}. With continuous verapamil treatment, the infection-associated reduction in adenylyl cyclase activity was less than 50{\%}. The individual components of the β-adrenergic receptor complex were characterized. Infection: (1) increased right ventricular (RV) β-adrenergic receptor (βAR) density five-fold; (2) decreased left ventricle βAR density by 20{\%}; (3) reduced the proportion of high-affinity βAR receptors to the same extent in both left and right ventricles; (4) reduced α(s) by 50{\%} as determined by Western blot analysis, increased α(il-3) but did not change a0; and (5) decreased the magnitude of pertussis-toxin-dependent [32P]ADP ribosylation by 60{\%} as well as the proportion of [32P]ADP-ribose incorporated in a0. Verapamil treatment of infected animals restored RV βAR receptor density, α(s) and α(il-3) to control levels but had no influence on any aspect of pertussis-toxin-dependent [32P]ADP-ribosylation. Verapamil treatment of uninfected animals also: (1) increased β-adrenergic adenylyl cyclase activity; (2) increased βAR density in the RV but not the LV; (3) reduced high- to low-affinity β-adrenergic receptors; and (4) affected only α(i2) (50{\%} decrease). The results indicate that the major actions of verapamil on the β-adrenergic adenylyl cyclase complex in acute canine Chagas' disease may help to account for its cardioprotective effects.",
keywords = "b-adrenergic receptor, Chagas' cardiomyopathy, Verapamil",
author = "Gexin Chen and Stephen Barr and Diane Walsh and Shira Rohde and Andrew Brewer and Bilezikian, {John P.} and Murray Wittner and Tanowitz, {Herbert B.} and Morris, {Stephen A.}",
year = "1996",
month = "5",
doi = "10.1006/jmcc.1996.0087",
language = "English (US)",
volume = "28",
pages = "931--941",
journal = "Journal of Molecular and Cellular Cardiology",
issn = "0022-2828",
publisher = "Academic Press Inc.",
number = "5",

}

TY - JOUR

T1 - Cardioprotective actions of verapamil on the β-adrenergic receptor complex in acute canine Chagas' disease

AU - Chen, Gexin

AU - Barr, Stephen

AU - Walsh, Diane

AU - Rohde, Shira

AU - Brewer, Andrew

AU - Bilezikian, John P.

AU - Wittner, Murray

AU - Tanowitz, Herbert B.

AU - Morris, Stephen A.

PY - 1996/5

Y1 - 1996/5

N2 - The effect of verapamil treatment on the myocardial β-adrenergic adenylyl cyclase complex in acute canine Chagas' disease was investigated. Relative to uninfected animals, 30 days of infection with T. cruzi reduced myocardial adenylyl cyclase activity by over 75%. With continuous verapamil treatment, the infection-associated reduction in adenylyl cyclase activity was less than 50%. The individual components of the β-adrenergic receptor complex were characterized. Infection: (1) increased right ventricular (RV) β-adrenergic receptor (βAR) density five-fold; (2) decreased left ventricle βAR density by 20%; (3) reduced the proportion of high-affinity βAR receptors to the same extent in both left and right ventricles; (4) reduced α(s) by 50% as determined by Western blot analysis, increased α(il-3) but did not change a0; and (5) decreased the magnitude of pertussis-toxin-dependent [32P]ADP ribosylation by 60% as well as the proportion of [32P]ADP-ribose incorporated in a0. Verapamil treatment of infected animals restored RV βAR receptor density, α(s) and α(il-3) to control levels but had no influence on any aspect of pertussis-toxin-dependent [32P]ADP-ribosylation. Verapamil treatment of uninfected animals also: (1) increased β-adrenergic adenylyl cyclase activity; (2) increased βAR density in the RV but not the LV; (3) reduced high- to low-affinity β-adrenergic receptors; and (4) affected only α(i2) (50% decrease). The results indicate that the major actions of verapamil on the β-adrenergic adenylyl cyclase complex in acute canine Chagas' disease may help to account for its cardioprotective effects.

AB - The effect of verapamil treatment on the myocardial β-adrenergic adenylyl cyclase complex in acute canine Chagas' disease was investigated. Relative to uninfected animals, 30 days of infection with T. cruzi reduced myocardial adenylyl cyclase activity by over 75%. With continuous verapamil treatment, the infection-associated reduction in adenylyl cyclase activity was less than 50%. The individual components of the β-adrenergic receptor complex were characterized. Infection: (1) increased right ventricular (RV) β-adrenergic receptor (βAR) density five-fold; (2) decreased left ventricle βAR density by 20%; (3) reduced the proportion of high-affinity βAR receptors to the same extent in both left and right ventricles; (4) reduced α(s) by 50% as determined by Western blot analysis, increased α(il-3) but did not change a0; and (5) decreased the magnitude of pertussis-toxin-dependent [32P]ADP ribosylation by 60% as well as the proportion of [32P]ADP-ribose incorporated in a0. Verapamil treatment of infected animals restored RV βAR receptor density, α(s) and α(il-3) to control levels but had no influence on any aspect of pertussis-toxin-dependent [32P]ADP-ribosylation. Verapamil treatment of uninfected animals also: (1) increased β-adrenergic adenylyl cyclase activity; (2) increased βAR density in the RV but not the LV; (3) reduced high- to low-affinity β-adrenergic receptors; and (4) affected only α(i2) (50% decrease). The results indicate that the major actions of verapamil on the β-adrenergic adenylyl cyclase complex in acute canine Chagas' disease may help to account for its cardioprotective effects.

KW - b-adrenergic receptor

KW - Chagas' cardiomyopathy

KW - Verapamil

UR - http://www.scopus.com/inward/record.url?scp=0030047380&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030047380&partnerID=8YFLogxK

U2 - 10.1006/jmcc.1996.0087

DO - 10.1006/jmcc.1996.0087

M3 - Article

VL - 28

SP - 931

EP - 941

JO - Journal of Molecular and Cellular Cardiology

JF - Journal of Molecular and Cellular Cardiology

SN - 0022-2828

IS - 5

ER -